EVG.L - Evgen Pharma plc

LSE - LSE Delayed price. Currency in GBp
Show:
Income statement
Balance sheet
Cash flow
Annual

Income statement

Currency in GBP. All numbers in thousands
Breakdown
ttm
31/03/2019
31/03/2018
31/03/2017
Total revenue
-
0
-
-
Operating expenses
Research development
-
1,689
-
-
Selling general and administrative
-
499
-
-
Total operating expenses
2,943
3,120
3,026
3,658
Operating income or loss
-2,943
-3,120
-3,026
-3,658
Interest expense
-
-
0
3
Income before tax
-2,943
-3,120
-3,026
-3,644
Income tax expense
-501
-496
-443
-576
Income from continuing operations
-2,442
-2,624
-2,583
-3,068
Net income
-2,442
-2,624
-2,583
-3,068
Net income available to common shareholders
-2,442
-2,624
-2,583
-3,068
Basic EPS
-
-0.03
-0.03
-0.04
Diluted EPS
-
-0.03
-0.03
-0.04
Basic average shares
-
95,857
78,697
73,153
Diluted average shares
-
95,857
78,697
73,153
EBITDA
-
-3,099
-3,005
-3,624
By using Yahoo, you agree that we and our partners can use cookies for purposes such as customising content and advertising. See our Privacy Policy to learn more